Quad-C Management Announces Investment in Pharm-Olam International
Charlottesville, VA. February 9, 2017 – Quad-C Management, Inc. (“Quad-C”), a leading middle market private equity firm, today announced it has closed an investment in Pharm-Olam International Ltd., a multinational, full-service clinical research organization (CRO), serving the biopharmaceutical and medical device industries. Terms of the transaction were not disclosed. Based in Houston, Texas, Pharm-Olam has 27 […]
